Skip to content

Insider · CIK 0002095702

Veronica Sanchez Bulis

officer

Files at LYEL (Lyell Immunopharma, Inc.). First filing Nov 12, 2025, latest Feb 11, 2026.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 3
$0 bought, $84k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

LYEL: Lyell Immunopharma, Inc.

LYELOct 9, 2026 · close 8.71

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
15Weak
LYELsell
Lyell Immunopharma, Inc.
$5,872
254 shares
-2%+204% from low-39% from high
28Weak
LYELsell
Lyell Immunopharma, Inc.
$74k
2,072 shares
-22%+395% from low0% from high
30Weak
LYELsell 4
Lyell Immunopharma, Inc.
$3,848
239 shares
-3%+127% from low-27% from high

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Feb 10, 2026LYEL
Lyell Immunopharma, Inc.
AGrant or award
Common Stock
+8,750$0.00$015,891Feb 11, 2026
Feb 10, 2026LYEL
Lyell Immunopharma, Inc.
SOpen-market sale
Common Stock
-254$23.12$5,87215,637Feb 11, 2026
Dec 24, 2025LYEL
Lyell Immunopharma, Inc.
SOpen-market sale
Common Stock
-1,136$38.67$44k8,077Jan 6, 2026
Dec 30, 2025LYEL
Lyell Immunopharma, Inc.
SOpen-market sale
Common Stock
-936$32.32$30k7,141Jan 6, 2026
Nov 10, 2025LYEL
Lyell Immunopharma, Inc.
SOpen-market sale
Common Stock
-239$16.10$3,8489,213Nov 12, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Veronica Sanchez Bulis: insider trades and track record | InsiderTell